By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – GeneNews today reported that it has cut its first-quarter net loss 30 percent, even though it had hardly any revenue for the period.

The Toronto-based molecular diagnostics firm brought in total revenues of just C$4,417 (US$4,298) for the three-month period ended March 31, compared to C$259,210 for the first quarter of 2009. The bulk of last year's revenues came from non-refundable license revenue, the firm said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: caution urged in use of gene drives, and more.

NIH's Sally Rockey examines the tapped and untapped potential of the NIH peer reviewer pool.

PLOS Biology has asked researchers how they envision the future of genetics and genomics.

Representative Lamar Smith brings back a provision to require the National Science Foundation to certify that each study it funds is "in the national interest."

Sep
17
Sponsored by
Omicia

This online seminar will provide examples of how commercial and hospital-affiliated clinical labs are successfully developing and deploying high-throughput next-generation sequencing-based testing services for genetic diseases. 

Oct
15
Sponsored by
Parabase

This webinar will discuss the benefits of a rapid targeted next-generation sequencing (TNGS) panel, using dried blood spots, for second-tier newborn metabolic and hearing loss screening and its immediate utility for high-risk diagnostic testing in the neonatal intensive care unit.